Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2015 1
2016 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis"
Page 1
Clinical characteristics and outcomes of exertional rhabdomyolysis after indoor spinning: a systematic review.
Masuda Y, Wam R, Paik B, Ngoh C, Choong AM, Ng JJ. Masuda Y, et al. Phys Sportsmed. 2023 Aug;51(4):294-305. doi: 10.1080/00913847.2022.2049645. Epub 2022 Mar 10. Phys Sportsmed. 2023. PMID: 35254210 Review.
OBJECTIVES: An increasing number of patients are diagnosed with exertional rhabdomyolysis secondary to indoor spinning. ...CONCLUSIONS: Healthcare professionals must have a high index of suspicion for SIER when a patient presents with myalgia, dark urine, or …
OBJECTIVES: An increasing number of patients are diagnosed with exertional rhabdomyolysis secondary to indoor spinning. ...CON …
HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review.
Kruijt N, van den Bersselaar LR, Wijma J, Verbeeck W, Coenen MJH, Neville J, Snoeck M, Kamsteeg EJ, Jungbluth H, Kramers C, Voermans NC. Kruijt N, et al. Neuromuscul Disord. 2020 Dec;30(12):949-958. doi: 10.1016/j.nmd.2020.10.010. Epub 2020 Oct 31. Neuromuscul Disord. 2020. PMID: 33250373 Free article.
The median age was 35 (range 4-84) years. Eight patients experienced recurrent episodes of rhabdomyolysis. Genetic analysis was performed in eleven patients (8%), revealing four RYR1 variants, three likely benign (p.Asp849Asn, p.Arg4645Gln, p.Arg4645Gln) and one var …
The median age was 35 (range 4-84) years. Eight patients experienced recurrent episodes of rhabdomyolysis. Genetic analysis wa …
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. Tait RJ, et al. Clin Toxicol (Phila). 2016;54(1):1-13. doi: 10.3109/15563650.2015.1110590. Epub 2015 Nov 15. Clin Toxicol (Phila). 2016. PMID: 26567470 Review.
CONTEXT: Synthetic cannabinoids (SCs) such as "Spice", "K2", etc. are widely available via the internet despite increasing legal restrictions. Currently, the prevalence of use is typically low in the general community (<1%) although it is higher among students and some …
CONTEXT: Synthetic cannabinoids (SCs) such as "Spice", "K2", etc. are widely available via the internet despite increasing legal rest …
Hypokalemic rhabdomyolysis in congenital tubular disorders: a case series and a systematic review.
von Vigier RO, Ortisi MT, La Manna A, Bianchetti MG, Bettinelli A. von Vigier RO, et al. Pediatr Nephrol. 2010 May;25(5):861-6. doi: 10.1007/s00467-009-1388-2. Epub 2009 Dec 22. Pediatr Nephrol. 2010. PMID: 20033223 Free article. Review.
Hypokalemia is a recognized cause of rhabdomyolysis but very few reports document its association with inborn renal tubular disorders. ...Five patients experienced two or more episodes of rhabdomyolysis. In 10 patients the underlying renal tubular disorder wa …
Hypokalemia is a recognized cause of rhabdomyolysis but very few reports document its association with inborn renal tubular disorders …
Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
Wojtowicz JM, Yarema MC, Wax PM. Wojtowicz JM, et al. CJEM. 2008 Jan;10(1):69-74. doi: 10.1017/s1481803500010034. CJEM. 2008. PMID: 18226321 Review.
We report a case of withdrawal from 1,4-BD lasting 6 days and complicated by new onset of seizures and rhabdomyolysis. In addition, we conducted a systematic review of the English literature pertaining to withdrawal from GHB, 1,4-BD and gamma-butyrolactone (GBL). ...The mo …
We report a case of withdrawal from 1,4-BD lasting 6 days and complicated by new onset of seizures and rhabdomyolysis. In addition, w …